Epiretinal membrane (ERM) is a common condition that affects the eyes of millions of people worldwide. It is a thin, transparent layer of tissue that forms on the surface of the retina, the light-sensitive layer of tissue at the back of the eye. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss. Despite its prevalence, the exact cause of ERM is still not fully understood. In this article, we will explore the current understanding of ERM and discuss the latest advances in diagnosis and treatment.
Epiretinal membrane is a thin, transparent layer of tissue that forms on the surface of the retina. It is composed of collagen and other proteins, and is usually caused by the contraction of scar tissue that forms after a retinal tear or detachment. In some cases, ERM can be caused by an inflammatory process or a reaction to a surgical procedure. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss.
ERM is typically diagnosed using a combination of physical examination, imaging tests, and other diagnostic techniques. During the physical examination, the doctor will look for signs of ERM, such as a retinal tear or detachment. Imaging tests, such as optical coherence tomography (OCT) and fluorescein angiography, can also be used to diagnose ERM. OCT is a non-invasive imaging technique that uses light to create detailed images of the retina. OCT can be used to detect the presence of ERM, as well as to evaluate the extent of the condition. Fluorescein angiography is a specialized imaging technique that uses a dye to highlight areas of the retina that are affected by ERM.
The treatment of ERM depends on the severity of the condition. In mild cases, treatment may not be necessary. However, in more severe cases, treatment may be necessary to prevent vision loss. The most common treatment for ERM is a surgical procedure called vitrectomy. During this procedure, the vitreous gel that fills the eye is removed and replaced with a gas or silicone oil bubble. This helps to reduce the tension on the retina and prevent further damage. In some cases, medications may be used to reduce inflammation and improve vision. Corticosteroids, such as prednisone, may be prescribed to reduce inflammation and improve vision.
Epiretinal membrane is a common condition that affects the eyes of millions of people worldwide. It is a thin, transparent layer of tissue that forms on the surface of the retina, the light-sensitive layer of tissue at the back of the eye. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss. Diagnosis of ERM typically involves a combination of physical examination, imaging tests, and other diagnostic techniques. Treatment of ERM depends on the severity of the condition and may include surgery, medications, or a combination of both. With the latest advances in diagnosis and treatment, doctors are now better equipped to diagnose and treat ERM and help patients preserve their vision.
1.
Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.
2.
Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.
3.
A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.
4.
Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.
5.
Pancreatic cancer RNA vaccine shows durable T cell immunity
1.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
2.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
3.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
4.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
5.
The Science Behind Thrombolytic Drugs and Their Benefits
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation